Peer-reviewed veterinary case report
Bushen Huoxue formula enhances anti-osteoarthritic efficacy of microfracture: Evidences for its mechanism of action.
- Journal:
- Phytomedicine : international journal of phytotherapy and phytopharmacology
- Year:
- 2026
- Authors:
- Chen, Zuxiang et al.
- Affiliation:
- The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine) · China
- Species:
- rodent
Abstract
BACKGROUND: Arthroscopic microfracture (MF) is a common treatment for osteoarthritis (OA) but has limited long-term efficacy, especially in the elderly. Bushen Huoxue formula (BHF), a traditional Chinese medicine, has potential in OA treatment, yet its mechanisms underlying the enhancement of MF efficacy remain unclear. PURPOSE: To identify the constituents of BHF, evaluate the efficacy of BHF in enhancing the anti-OA effect of MF, and decipher the underlying mechanisms. METHODS: The chemoprofile of BHF was characterized using UPLC-Q/TOF-MS. OA model in rats was established using monosodium iodoacetate (MIA), and the therapeutic effect of BHF-MF combinatorial treatment was assessed through behavioral test, histopathology, and micro-CT. The migratory potential of BMSCs was evaluated using wound healing and transwell assays. The autophagy related mechanism was screened through network pharmacology, which was validated by Western blot and confocal imaging of autophagic flux in BMSCs. The requirement for autophagy was tested using chloroquine, siATG5, and siAMPK in vitro and by intra-tibial AAV-shATG5 or AAV-shAMPK delivery in vivo. RESULTS: 168 compounds were identified within BHF. In vivo studies demonstrated that BHF significantly improved the therapeutic efficacy of MF in OA rats. In vitro findings indicated that BHF enhanced the migratory capacity of BMSCs. Network pharmacology and experimental validation revealed that BHF promotes autophagy in BMSCs through the AMPK-mTOR pathway. CONCLUSIONS: This study presents, for the first time, the enhancing effect of BHF on MF in combating OA, offering a novel therapeutic strategy to enhance the clinical efficacy of MF against OA.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/41447847/